Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
If you are pregnant, nursing, taking medication, or have any medical condition, consult your healthcare professional before use
NIA P30AG013319 to Y.I
10.1016/j.bcp.2004.03.047 Biochem
Key Points The growth hormone (GH)insulin-like growth factor (IGF) axis consists of central neuro-anatomical, regulatory and genetic systems, and the peripheral intracellular GH signalling pathway The introduction of recombinant human GH (rhGH) in 1985 ended the phase of pituitary-derived human growth hormone (hGH) and its associated limitations and risks, opening the possibility of widespread clinical use GH deficiency (GHD) is a syndrome with many different causes and is associated with alterations in growth, body composition and metabolism In some non-GHD short stature disorders, rhGH has been proved effective and is used as a surrogate for the currently unknown, pathophysiologically appropriate treatment Risks of hGH therapy might relate to its direct effects on growth, its anti-insulin action and its cell-proliferating activity
L-Carnitine and the Heart L-Carnitine has several potential benefits for heart health
US$ 26.20
US$ 23.20
US$ 26.08
US$ 23.51
US$ 25.42
